151 related articles for article (PubMed ID: 38558541)
1. Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies: A systematic review and meta-analysis.
Anabtawi NM; Pasala MS; Grimshaw AA; Kharel P; Bal S; Godby K; Siwakoti A; Buford TW; Bhatia S; Costa LJ; Williams GR; Giri S
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1084-1093. PubMed ID: 38558541
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal Cancer: A Systematic Review and Meta-Analysis.
Meyer HJ; Strobel A; Wienke A; Surov A
Clin Colorectal Cancer; 2022 Sep; 21(3):e213-e225. PubMed ID: 35792019
[TBL] [Abstract][Full Text] [Related]
3. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients.
Basile D; Parnofiello A; Vitale MG; Cortiula F; Gerratana L; Fanotto V; Lisanti C; Pelizzari G; Ongaro E; Bartoletti M; Garattini SK; Andreotti VJ; Bacco A; Iacono D; Bonotto M; Casagrande M; Ermacora P; Puglisi F; Pella N; Fasola G; Aprile G; Cardellino GG
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):368-377. PubMed ID: 30719874
[TBL] [Abstract][Full Text] [Related]
4. Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.
Surov A; Pech M; Gessner D; Mikusko M; Fischer T; Alter M; Wienke A
Clin Nutr; 2021 Oct; 40(10):5298-5310. PubMed ID: 34536638
[TBL] [Abstract][Full Text] [Related]
5. CT-defined low-skeletal muscle mass as a prognostic marker for survival in prostate cancer: A systematic review and meta-analysis.
Meyer HJ; Wienke A; Surov A
Urol Oncol; 2022 Mar; 40(3):103.e9-103.e16. PubMed ID: 34483042
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis.
March C; Omari J; Thormann M; Pech M; Wienke A; Surov A
Clin Nutr ESPEN; 2022 Jun; 49():103-113. PubMed ID: 35623801
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia as a Prognostic Marker for Survival in Gastric Cancer Patients Undergoing Palliative Chemotherapy. A Systematic Review and Meta Analysis.
Meyer HJ; Wienke A; Surov A
Nutr Cancer; 2022; 74(10):3518-3526. PubMed ID: 35603926
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.
Shachar SS; Williams GR; Muss HB; Nishijima TF
Eur J Cancer; 2016 Apr; 57():58-67. PubMed ID: 26882087
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Effect of Low Skeletal Muscle Mass among Hepatocellular Carcinoma Patients Undergoing Systemic Therapy: A Systematic Review and Meta-Analysis.
Kuo MH; Tseng CW; Hsu CS; Chen YC; Kao IT; Wu CY; Shao SC
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173893
[TBL] [Abstract][Full Text] [Related]
10. Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis.
Meyer HJ; Wienke A; Zamsheva M; Surov A
Urol Int; 2023; 107(3):219-229. PubMed ID: 36455534
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
[TBL] [Abstract][Full Text] [Related]
13. Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-Analysis.
Chen YC; Kuo MH; Hsu CS; Kao IT; Wu CY; Tseng CW; Shao SC
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254808
[TBL] [Abstract][Full Text] [Related]
14. Low skeletal muscle mass in cholangiocarcinoma treated by surgical resection. A meta-analysis.
Surov A; Pech M; Omari J; Melekh B; March C; Perrakis A; Wienke A
HPB (Oxford); 2022 Jul; 24(7):997-1006. PubMed ID: 34906379
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and mortality risk of low skeletal muscle mass in critically ill patients: an updated systematic review and meta-analysis.
Yang H; Wan XX; Ma H; Li Z; Weng L; Xia Y; Zhang XM
Front Nutr; 2023; 10():1117558. PubMed ID: 37252244
[TBL] [Abstract][Full Text] [Related]
16. Interstitial Brachytherapy for Hepatocellular Carcinoma: Analysis of Prognostic Factors for Overall Survival and Progression-Free Survival and Application of a Risk Stratification Model.
Thormann M; Heitmann F; Wrobel V; Heinze C; March C; Hass P; Damm R; Surov A; Pech M; Omari J
Dig Dis; 2023; 41(6):957-966. PubMed ID: 37385234
[TBL] [Abstract][Full Text] [Related]
17. Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.
Rinninella E; Cintoni M; Raoul P; Pozzo C; Strippoli A; Bria E; Tortora G; Gasbarrini A; Mele MC
Clin Nutr; 2020 Jul; 39(7):2045-2054. PubMed ID: 31718876
[TBL] [Abstract][Full Text] [Related]
18. The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis.
Huiskamp LFJ; Chargi N; Devriese LA; May AM; Huitema ADR; de Bree R
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238530
[TBL] [Abstract][Full Text] [Related]
19. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.
Aldin A; Umlauff L; Estcourt LJ; Collins G; Moons KG; Engert A; Kobe C; von Tresckow B; Haque M; Foroutan F; Kreuzberger N; Trivella M; Skoetz N
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012643. PubMed ID: 31930780
[TBL] [Abstract][Full Text] [Related]
20. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.
Aldin A; Umlauff L; Estcourt LJ; Collins G; Moons KG; Engert A; Kobe C; von Tresckow B; Haque M; Foroutan F; Kreuzberger N; Trivella M; Skoetz N
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD012643. PubMed ID: 31525824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]